Spring Valley Acquisition Corp. III
Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Aug 6, 2025
Contents
Cover page
Show cover page
As filed with the U.S. Securities and Exchange Commission on August 4, 2025.
Registration No. 333-[·]
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM****S-1
REGISTRATION STATEMENT**
**UNDER
THE SECURITIES ACT OF 1933
(Exact Name of Registrant as Specified in its Charter)
| Cayman Islands | 6770 | N/A |
|---|---|---|
| (State or Other Jurisdiction of | (Primary Standard Industrial | (IRS Employer |
| Incorporation or Organization) | Classification Code Number) | Identification Number) |
2100 McKinney Ave., Suite 1675
Dallas, TX 75201
Tel: (214) 308-5230
(Address, including Zip Code, and Telephone Number, including Area Code, of Registrant’s Principal Executive Offices)
Christopher Sorrells**
**Chief Executive Officer
2100 McKinney Ave., Suite 1675
Dallas, TX 75201
Tel: (214) 308-5230
(Name, Address, including Zip Code, and Telephone Number, including Area Code, of Agent for Service)
Copies to:
| Alan Annex, Esq. | Matthew R. Pacey, P.C. |
|---|---|
| Jason Simon, Esq. | Kirkland & Ellis LLP |
| Greenberg Traurig, LLP | 609 Main Street |
| 1750 Tysons Boulevard, Suite 1000 | Houston, TX 77002 |
| McLean, Virginia 22102 | Tel: (713) 836-3600 |
| Tel: (703) 749-1300 | |
**Approximate date of commencement of proposed sale to the public:**As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.☐
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information contained in this preliminary prospectus is not complete and may be changed. No securities may be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED AUGUST 4, 2025
PRELIMINARY PROSPECTUS
$150,000,000
15,000,000 Units
Spring Valley Acquisition Corp. III is a blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. Our efforts to identify a prospective initial business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any business, industry or geographic location, we intend to capitalize on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team’s established global relationships, sector expertise and active management and operating experience. In particular, we currently intend to focus on opportunities that capitalize on the expertise and ability of our management team, particularly our executive officers, to identify, acquire and operate a business in the natural resources and decarbonization industries.
We are an “emerging growth company” and “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements.Investing in our securities involves risks. See “Risk Factors” beginning on page48**. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.**
| · · · · · · | |||
|---|---|---|---|
| · · · Underwriting · · | |||
| · · · · Discounts and · · Proceeds, Before | |||
| · · Price to Public · · Commissions(1) · · Expenses, to Us | |||
| Per Unit | 10.00 | 0.60 | 9.40 |
| Total | 150,000,000 | 9,000,000 | 140,250,000 |
| (1) | Includes (a) $0.20 per unit, or $3,000,000 in the aggregate (or $3,450,000 if the overallotment option is exercised in full), payable to the underwriters upon the closing of this offering, of which (i) $0.10 per unit will be paid to the underwriters in cash and (ii) $0.10 per unit will be used by the underwriters to purchase private placement warrants; and (b) up to $0.40 per unit, or $6,000,000 in the aggregate (or up to $6,900,000 in the aggregate if the overallotment option is exercised in full) payable to the underwriters in this offering, for deferred underwriting commissions, to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination, but such $0.40 per unit shall be due solely on amounts remaining in the trust account following all properly submitted shareholder redemptions in connection with the consummation of our initial business combination. Does not include certain fees and expenses payable to the underwriters in connection with this offering. See also “Underwriting” for additional information regarding underwriting compensation. |
Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $150,000,000 (or $172,500,000 if the underwriters’ over-allotment option is exercised in full) ($10.00 per unit), will be deposited into a U.S.-based trust account maintained with [●] acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to us to as described below, and up to $100,000 to pay dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest to occur of: (1) our completion of an initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or such earlier liquidation date as our board of directors may approve, or such later time as provided for in any amendment to our amended and restated memorandum and articles of association (an “Extension Period”), subject to applicable law, or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of our public shares if we have not completed an initial business combination within 24 months from the closing of this offering, or such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of our creditors, if any, which could have priority over the claims of our public shareholders. We are permitted to withdraw amounts from the trust account (i) to fund our working capital requirements, which amount shall not equal more than 5% of the interest earned on the trust account, and/or (ii) to pay our taxes, provided that all permitted withdrawals can only be made (x) from interest and not from the principal held in the trust account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount (“permitted withdrawals”).
The underwriters are offering the units for sale on a firm commitment basis. Delivery of the units will be made on or about, 2025.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
No invitation, whether directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our securities.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable public warrant. Each whole public warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as provided herein, and only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The public warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, and will expire seven years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. We have also granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments, if any.
We will provide our public shareholders with theopportunity to redeem, regardless of whether they abstain, vote for, or against, our initial business combination, all or a portion of their Class A ordinary shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account described below calculated as of two business days prior to the completion of our initial business combination, including interest earned on the funds held in the trust account (which interest shall be net of permitted withdrawals) to pay our taxes, if any, divided by the number of then issued and outstanding Class A ordinary shares that were sold as part of the units in this offering, which we refer to collectively as our public shares, subject to the limitations described herein. Notwithstanding the foregoing redemption rights, if we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended), is restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in this offering, without our prior consent. We will have 24 months from the closing of this offering to consummate an initial business combination or until such earlier liquidation date as our board of directors may approve, or during any Extension Period, subject to applicable law. However, we may seek the approval of our shareholders at any time to amend our amended and restated memorandum and articles of association to modify the amount of time we will have to consummate an initial business combination (as well as to modify the substance or timing of our obligation to redeem 100% of our public shares if we have not consummated an initial business combination within the time periods described herein or with respect to any other material provisions relating to shareholders’ rights or pre- initial business combination activity). As
described herein, our initial shareholders, executive officers, and directors have agreed that they will not propose any such amendment unless we provide our public shareholders with the opportunity to redeem their public shares upon approval of any such amendment at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of amounts withdrawn for permitted withdrawals), divided by the number of then-outstanding public shares, subject to the limitations described herein. See “Proposed Business Redemption of Public Shares and Liquidation if no Initial Business Combination” for more information.
If we have not completed our initial business combination within 24 months from the closing of this offering or such earlier liquidation date as our board of directors may approve, orduring any Extension Period, subject to applicable law, we will redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned thereon (which interest shall be net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses) andnot previously released to us to pay our taxes, if any, divided by the number of then issued and outstanding public shares, subject to applicable law and certain conditions as further described herein.
Our sponsor, Spring Valley Acquisition III Sponsor, LLC, a Delaware limited liability company (which we refer to throughout this prospectus as our “Sponsor”), has committed to purchase an aggregate of 5,333,333 private placement warrants (or 5,583,333 private placement warrants if the underwriters’ over- allotment option is exercised in full) at a price of $0.90 per private placement warrant, or $4,800,000 in the aggregate (or $5,025,000 if the underwriters’ overallotment option is exercised in full) in a private placement that will close simultaneously with the closing of this offering. The underwriters have committed to use a portion of their underwriting discount and commission to purchase an aggregate of 1,666,667 private placement warrants (or 1,916,667 private placement warrants in the aggregate if the underwriters’ over- allotment option is exercised in full) at a price of $0.90 per warrant, or $1,500,000 in the aggregate (or $1,725,000 in the aggregate if the underwriters’ overallotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering. The private placement warrants are identical to the warrants included in the units sold in this offering, subject to certain limited exceptions as described in this prospectus. See “Summary — The Offering — Private Placement Warrants.”
Our Sponsor and the three independent directors that will hold our founder shares prior to this offering (which we refer to as our “initial shareholders” as further described herein) currently hold 5,750,000 Class B ordinary shares (which we refer to as “founder shares” as further described herein), up to 750,000 of which are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over- allotment option is exercised, for an aggregate purchase price of $25,000, or approximately $0.004 per share. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of our initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment as provided herein. Prior to our initial business combination, holders of the Class B ordinary shares will have the right to vote to appoint all of our directors and may remove members of the board of directors for any reason. On any other matter submitted to a vote of our shareholders, holders of the Class B ordinary shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law. See*“Summary — The Offering — Founder Shares”; “Summary — The Offering — Transfer restrictions on founder shares”; “Summary — The Offering — Appointment of directors; Voting rights”; and “*Summary — The Offering — Private Placement Warrants,” for further discussion on our Sponsor’s and our affiliates’ securities and compensation.
Our Sponsor has agreed to loan us up to $250,000 under an unsecured promissory note, dated March 28, 2025, to be used for a portion of the expenses of this offering. This loan is non-interest bearing, and the outstanding balance of this loan will be payable on the earlier of: (i) December 31, 2025, and (ii) the date on which we consummate an initial public offering. In addition, in order to finance transaction costs in connection with an intended initial business combination, either of our Sponsor, any of its affiliates or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Upon consummation of this offering, we may repay any loans made to us by our Sponsor, to cover offering-related and organizational expenses. In the event that following this offering we obtain working capital loans from our Sponsor or an affiliate to finance transaction costs related to our initial business combination, up to $1,500,000 of such loans may be convertible into warrants at a price of $0.90 per warrant at the option of the lender. Commencing on the date on which our securities are listed on Nasdaq, we may make certain payments and reimbursements, or pay certain fees, to our Sponsor, officers or directors, or our or their affiliates. Our Sponsor has also agreed to provide office space and administrative services to us at a price of $20,000 per month. See the section titled “Summary - Sponsor Information” for more information regarding, among other things, the amount of compensation and securities received or to be received by our sponsors, their affiliates and our officers and directors.
Because our Sponsor acquired the founder shares at a nominal price of approximately $0.004 per share, our public shareholders will incur immediateand substantial dilution upon the closing of this offering, assuming no value is ascribed to the warrants included in the units. See the section titled “Risk Factors — Risks Relating to our Sponsor and Management Team — The nominal purchase price paid by our Sponsor and certain of our independent directors for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination*.*”
The following table illustrates the difference between the public offering price and our net tangible book value (“NTBV”), as adjusted to give effect to this offering and to redemptions of our public shares at varying levels, assuming the full exercise and no exercise of the over-allotment option. See the sections titled “Prospectus Summary — Dilution” and “Dilution” for more information.
| · · · · · · · · · · · · · · · · · · · · · · · · | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As of May 21, 2025 | ||||||||||||||||
| Offering Price of · · 25% of Maximum · · 50% of Maximum · · 75% of Maximum · · · · · | ||||||||||||||||
| $10.00 per Unit · · Redemption · · Redemption · · Redemption · · Maximum Redemption | ||||||||||||||||
| · · · · · Difference · · · · · Difference · · · · · Difference · · · · · Difference | ||||||||||||||||
| · · · · · between · · · · · between · · · · · between · · · · · between | ||||||||||||||||
| · · · · · Public NTBV · · · · · NTBV and · · · · · NTBV and · · · · · NTBV and | ||||||||||||||||
| · · · · · and Public · · · · · Offering · · · · · Offering · · · · · Offering | ||||||||||||||||
| NTBV · NTBV · Offering Price · NTBV · Price · NTBV · Price · NTBV · Price | ||||||||||||||||
| | | | | | | | | | | | | | | | | |
| Assuming Full Exercise of Over-Allotment Option | ||||||||||||||||
| $7.31 | | $6.79 | | $3.21 | | $5.94 | | $4.06 | | $4.37 | | $5.63 | | $0.45 | | $9.55 |
| Assuming No Exercise of Over-Allotment Option | ||||||||||||||||
| $7.32 | | $6.80 | | $3.20 | | $5.96 | | $4.04 | | $4.39 | | $5.61 | | $0.49 | | $9.51 |
Our Sponsor and members of our management team will directly or indirectly own our securities following this offering, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. Further, each ofour officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. Additionally, each of our officers and directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entities. See the section titled*“*Management — Conflicts of Interest.”
Prior to this offering, there has been no public market for our units, Class A ordinary shares or public warrants. We have applied to list our units on The Nasdaq Global Market (“Nasdaq”) under the symbol “SVACU” on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on Nasdaq. The closing of this offering is contingent upon the successful listing of our common stock on Nasdaq. The Class A ordinary shares and public warrants constituting the units will begin separate trading on the 52 nd day following the date of this prospectus (or, if such date is not a business day, the following business day) unless Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”), the representative of the underwriters, informs us of its decision to allow earlier separate trading, subject to our satisfaction of certain conditions as described further herein. Once the securities constituting the units begin separate trading, we expect that the Class A ordinary shares and warrants will be listed on Nasdaq under the symbols “SVAC” and “SVACW,” respectively.
We are responsible for the information contained in this prospectus. We have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the units offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.
Sole Book-Running Manager
Cohen & Company Capital Markets
The date of this prospectus is , 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.